Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin Phosphate Bioequivalence in Acne Vulgaris
NCT04321070Phase 1Completed
- Start
- Sep 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of clindamycin in acne vulgaris (3 arms). Primary endpoint: Demonstration of Bioequivalence at Week 12. Started Sep 2019; status: completed.
02
Drugs
clindamycin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT04321070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04321070.